By analyzing Oncomine data derived from Haferlach et al., [23] we determined that DNMT1, DNMT3A and DNMT3B mRNA expression levels are elevated in clinical T-ALL compared to non-malignant cells (Figure 2A). The gene discussed is DNMT1; the disease is acute lymphoblastic leukemia.